Clare Kelly, MD
-
Specialty: Endocrinology
View Expertise -
Primary Location: 6529 Euclid Ave (2 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Cleveland Midtown Collaboration Center (2 mi.)
6529 Euclid Ave
Midtown Collaboration Center
Cleveland, OH 44103
216-675-6720
University Hospitals (7 mi.)
5885 Landerbrook Dr
Ste 100
Mayfield Heights, OH 44124
216-286-8988
UH St John Health Center (16 mi.)
26908 Detroit Rd
Ste 201
Westlake, OH 44145
440-835-6142
Biography: Clare Kelly, MD
Expertise
Certifications & Memberships
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Endocrinology, Diabetes and Metabolism
Endocrinology, Diabetes and Metabolism - The Ohio State University Wexner Medical Center (2022 - 2024)
Residency | Internal Medicine
Internal Medicine - UH Cleveland Medical Center (2019 - 2022)
Medical Education
University Of Toledo College Of Medicine (2019)
Undergraduate
University Of Dayton (2015)
About
Clare Kelly, MD, is an endocrinologist at the University Hospitals Diabetes and Metabolic Care Center specializing in the diagnosis and treatment of patients with diabetes and metabolic disorders. Dr. Kelly is board certified in internal medicine and endocrinology, diabetes and metabolism.
Dr. Kelly earned her medical degree from the University of Toledo College of Medicine in Toledo, Ohio. Her postdoctoral training began with an internal medicine residency at University Hospitals Cleveland Medical Center. She then completed an endocrinology, diabetes and metabolism fellowship at The Ohio State University Wexner Medical Center in Columbus, Ohio.
Dr. Kelly has been involved in several research projects and has published multiple peer-reviewed publications, presentations and abstracts on endocrinology care topics, including thyroid, A1C measurements and hyperglycemia.
Research & Publications
Research Interests
Endocrinology care including thyroid, A1C measurements and hyperglycemia
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Clare Kelly did not disclose any Outside Relationships with Industry.